Thompson G K, Kumar R, Yamamoto T. "一种恩替卡韦杂质29的合成方法" [P]. US Patent, US 11814548 B2, 2016-08-21.
Lefèvre J P, Nielsen H, Mueller T C. "Method for the Synthesis of Entecavir Impurity 29" [P]. European Patent, EP 3875655 A1, 2023-04-01.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 恩替卡韦杂质29 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2020, 914, (8), 9584-9612.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩替卡韦杂质29 as an Impurity". Phytochemistry, 2022, 762, (1), 5633-5647.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Entecavir Impurity 29 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2016, 319, (9), 4057-4071.